---

---

tags : Treatment    symbols : NVS   

save search

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.155 -1.46% 4.1M |

Health Technology

| 0.0% | O: -0.71% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K |

Health Technology

| 0.22% | O: -1.46% H: 0.0% C: 0.0%
PHG | $20.33 -0.39% 490K |

Health Technology

| 0.0% | O: -1.21% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| 0.0% | O: -1.63% H: 0.0% C: 0.0%
VRNA | $16.29 3.1% 380K |

Health Technology

| 0.0% | O: 1.27% H: 0.0% C: 0.0%
reach treatment research market

---

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| -0.16% | O: 0.32% H: 0.04% C: -0.56%
ARVN | $33.97 -2.16% 200K |

Health Technology

| -3.9% | O: 8.28% H: 0.56% C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement

---

Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 82K |

Health Technology

| -2.86% | O: -100.0% H: NaN% C: Infinity%
NVS | $92.99 -1.5% 990K |

Health Technology

| -1.89% | O: -0.08% H: 0.15% C: -0.44%
LLY | $749.215 -0.21% 1.4M |

Health Technology

| -2.57% | O: 0.06% H: 0.96% C: 0.26%
CAH | $107.15 0.11% 440K |

Distribution Services

| -3.59% | O: 0.02% H: 0.73% C: -0.02%
LNTH | $62.16 3.17% 280K |

Health Technology

| 2.08% | O: 0.1% H: 1.98% C: -0.08%
reach cancer treatment market

---

Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published: 2024-02-29 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| -3.76% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | $93.6375 82K |

Health Technology

| -7.38% | O: 0.89% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K |

Health Technology

| -6.5% | O: 1.03% H: 0.14% C: 0.05%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -8.55% | O: 0.28% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| -3.34% | O: 0.26% H: 0.18% C: 0.05%
BMY | $48.365 -0.3% 4.9M |

Health Technology

| -4.41% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

---

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | $135.94 770 |

Health Technology

| 10.07% | O: -0.57% H: 0.04% C: -1.74%
NVS | $92.99 -1.5% 990K |

Health Technology

| -6.55% | O: -1.46% H: 1.04% C: 0.97%
LLY | $749.215 -0.21% 1.4M |

Health Technology

| 1.43% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.365 -0.3% 4.9M |

Health Technology

| -2.61% | O: 0.02% H: 0.46% C: -0.14%
ABBV | $163.42 1.08% 2M |

Health Technology

| -7.61% | O: -0.83% H: 0.7% C: -0.27%
ABT | $109.92 0.95% 3.2M |

Health Technology

| -2.99% | O: -0.64% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K |

Health Technology

| 0.58% | O: -0.86% H: 0.0% C: 0.0%
AZN | $68.38 -0.51% 2.1M |

Health Technology

| 10.39% | O: -1.77% H: 0.46% C: 0.41%
AMGN | $264.955 -0.21% 880K |

Health Technology

| -8.8% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

---

Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published: 2024-01-17 (Crawled : 02:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | $92.966 630 |

Health Technology

| -10.52% | O: -1.83% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K |

Health Technology

| -12.33% | O: 0.49% H: 0.18% C: 0.04%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -8.85% | O: -1.02% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| 1.55% | O: -0.08% H: 0.1% C: -0.18%
ABT | $109.92 0.95% 3.2M |

Health Technology

| -4.04% | O: 0.12% H: 0.77% C: 0.27%
SNY | $46.19 0.57% 580K |

Health Technology

| -9.29% | O: 0.45% H: 0.06% C: -0.5%
GILD | $67.44 -0.46% 2.3M |

Health Technology

| -21.21% | O: -0.19% H: 0.87% C: 0.76%
report infection treatment global market

---

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | $9.48 1.7K |

Health Technology

| -23.3% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | $93.6375 82K |

Health Technology

| -11.87% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | $9.2715 500K |

Manufacturing

| -24.5% | O: -1.22% H: 0.0% C: -0.72%
NVS | $92.99 -1.5% 990K |

Health Technology

| -11.83% | O: -0.46% H: 0.74% C: -0.19%
SNY | $46.19 0.57% 580K |

Health Technology

| -9.04% | O: 0.74% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K |

Health Technology

| -14.59% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

---

Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories
Published: 2023-12-19 (Crawled : 19:00) - prnewswire.com
SNYNF | $92.966 630 |

Health Technology

| -3.13% | O: -0.39% H: 1.49% C: 0.32%
NVSEF | $93.6375 82K |

Health Technology

| -2.97% | O: 0.8% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K |

Health Technology

| -3.95% | O: -0.15% H: 0.27% C: -1.02%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -4.96% | O: 0.73% H: 0.0% C: 0.0%
ABT | $109.92 0.95% 3.2M |

Health Technology

| 0.77% | O: 0.01% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K |

Health Technology

| -3.7% | O: 0.21% H: 0.0% C: 0.0%
disorders treatment pharmaceuticals global market

---

Global Melanoma Treatment Market Report 2023, Featuring Comprehensive Profiles of Leading Players including Amgen, Roche, Merck & Co., Pfizer Inc., BMS and Novartis
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| -5.32% | O: -1.67% H: 1.17% C: 0.85%
ARMK | $31.385 -0.27% 490K |

Consumer Services

| 15.91% | O: 0.88% H: 1.88% C: 0.69%
melanoma report merck treatment global novartis market

---

Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio
Published: 2023-11-20 (Crawled : 19:00) - prnewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| -0.88% | O: 0.91% H: 0.6% C: 0.27%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| 15.35% | O: 0.51% H: 0.77% C: 0.26%
BAX | $39.79 -0.62% 1.3M |

Health Technology

| 12.41% | O: 0.39% H: 0.2% C: -0.17%
america treatment growth market

---

Novartis data show potential of remibrutinib as an oral treatment for chronic spontaneous urticaria providing significant symptom improvement as early as Week 2
Published: 2023-11-09 (Crawled : 16:00) - globenewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| 0.03% | O: -0.26% H: 0.04% C: -0.96%
urticaria treatment novartis week potential show

---

Global Thyroid Gland Disorder Treatment Market Set to Reach USD 3.15 Billion by 2030, Reveals Infinium Global Research
Published: 2023-11-03 (Crawled : 09:00) - prnewswire.com
NVSEF | $93.6375 82K |

Health Technology

| 0.42% | O: -1.88% H: 3.51% C: 2.73%
NVS | $92.99 -1.5% 990K |

Health Technology

| 0.35% | O: -1.4% H: 0.42% C: 0.0%
ABBV | $163.42 1.08% 2M |

Health Technology

| 14.46% | O: 1.88% H: 0.0% C: 0.0%
ABT | $109.92 0.95% 3.2M |

Health Technology

| 14.51% | O: 2.0% H: 0.0% C: 0.0%
reach treatment thyroid research global set market

---

Clonidine Micropellet Epidural Injections Fuel Growth in Global Sciatica Treatment Market
Published: 2023-11-01 (Crawled : 23:00) - prnewswire.com
VTRS | $11.155 -1.46% 4.1M |

Health Technology

| 26.91% | O: 0.67% H: 0.22% C: -0.56%
NVS | $92.99 -1.5% 990K |

Health Technology

| 0.16% | O: -1.09% H: 1.03% C: 0.91%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -0.93% | O: -0.89% H: 0.0% C: 0.0%
SNY | $46.19 0.57% 580K |

Health Technology

| 2.7% | O: 3.0% H: 0.0% C: 0.0%
treatment global growth market

---

FDA approves Novartis Cosentyx® as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade
Published: 2023-10-31 (Crawled : 21:00) - globenewswire.com
NVSEF | $93.6375 82K |

Health Technology

| 2.99% | O: 2.52% H: 0.04% C: 0.04%
NVS | $92.99 -1.5% 990K |

Health Technology

| 0.89% | O: 0.16% H: 0.7% C: 0.57%
cosentyx fda treatment novartis

---

Global Paronychia Treatment Market Size Expected to Grow by USD 933.78 Million By 2032, With 7.2% CAGR Rise: Polaris Market Research
Published: 2023-10-13 (Crawled : 14:30) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 10.26% | O: -1.42% H: 0.0% C: 0.0%
NVS | $92.99 -1.5% 990K |

Health Technology

| -3.54% | O: -0.55% H: 0.69% C: -0.09%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -5.23% | O: 0.64% H: 0.0% C: 0.0%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| 9.43% | O: -0.3% H: 0.72% C: -0.6%
expected treatment research global market

---

Global HIV Drugs Market Research Report 2023-2031: Long-Acting Injectable HIV Therapies Redefining the Treatment Landscape
Published: 2023-10-02 (Crawled : 17:00) - prnewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| -7.31% | O: 0.19% H: 0.03% C: -0.5%
BMY | $48.365 -0.3% 4.9M |

Health Technology

| -16.42% | O: -0.05% H: 0.09% C: -0.28%
SNY | $46.19 0.57% 580K |

Health Technology

| -12.62% | O: 0.78% H: 0.0% C: 0.0%
report treatment research global hiv market

---

Dry Eye Syndrome Treatment Market to Reach $9.3 Billion, Globally, by 2032 at 7.1% CAGR: Allied Market Research
Published: 2023-09-29 (Crawled : 09:00) - prnewswire.com
NVS | $92.99 -1.5% 990K |

Health Technology

| -7.74% | O: 1.18% H: 0.06% C: -1.62%
JNJ | $145.405 -1.48% 7.6M |

Health Technology

| -6.3% | O: -0.25% H: 0.0% C: 0.0%
reach treatment research eye market

---

The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published: 2023-09-25 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 8.89% | O: -0.81% H: 1.63% C: -1.03%
NVSEF | $93.6375 82K |

Health Technology

| 12.99% | O: 3.72% H: 0.0% C: 0.0%
VTRS | $11.155 -1.46% 4.1M |

Health Technology

| 17.43% | O: -0.21% H: 1.14% C: 1.04%
NVS | $92.99 -1.5% 990K |

Health Technology

| -6.65% | O: -0.31% H: 0.98% C: 0.97%
GSK | $40.035 -1.15% 1.5M |

Health Technology

| 8.2% | O: -0.13% H: 0.91% C: 0.88%
ABBV | $163.42 1.08% 2M |

Health Technology

| 5.66% | O: -0.24% H: 0.0% C: 0.0%
ABT | $109.92 0.95% 3.2M |

Health Technology

| 10.12% | O: -1.17% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K |

Health Technology

| -0.82% | O: -0.06% H: 0.1% C: -0.25%
abbvie treatment thyroid market

---

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Projected to Reach $6.17 Billion by 2030: Increasing Prevalence Drives Growth
Published: 2023-09-22 (Crawled : 19:00) - prnewswire.com
NVSEF | $93.6375 82K |

Health Technology

| Email alert Add to watchlist
GLPGF | $35.5157 71.75% 4.8K |

Health Technology

| Email alert Add to watchlist
NVS | $92.99 -1.5% 990K |

Health Technology

| Email alert Add to watchlist
BMY | $48.365 -0.3% 4.9M |

Health Technology

| Email alert Add to watchlist
LMNL | $8.5 0.12% 0.12% 0 |

Health Technology

| Email alert Add to watchlist
GLPG | $29.495 -1.02% 150K |

Health Technology

| Email alert Add to watchlist
reach treatment fibrosis global growth market

---

Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
UCBJY | $63.0 11K |

Manufacturing

| 39.41% | O: -0.79% H: 0.0% C: -1.26%
NVS | $92.99 -1.5% 990K |

Health Technology

| -8.85% | O: -0.7% H: 0.06% C: -0.75%
LLY | $749.215 -0.21% 1.4M |

Health Technology

| 30.85% | O: -1.47% H: 0.0% C: 0.0%
ABBV | $163.42 1.08% 2M |

Health Technology

| 5.16% | O: -0.04% H: 0.76% C: -0.16%
SNY | $46.19 0.57% 580K |

Health Technology

| -15.41% | O: -1.16% H: 0.0% C: 0.0%
AMGN | $264.955 -0.21% 880K |

Health Technology

| -2.19% | O: 0.22% H: 0.15% C: -0.98%
psoriasis treatment novartis

---

Gainers vs Losers

55%

45%

Top 10 Gainers

WISA 4 | $5.33 204.57% 190M |

Electronic Technology

TPET | $0.5189 124.54% 38M |

n/a

SXTC | $1.78 52.14% 33M |

Health Technology

JAGX | $0.1771 49.07% 540M |

Health Technology

DYNT | $0.52 40.39% 20M |

Health Technology

BSGM | $1.53 39.09% 2.6M |

Health Technology

MCBC | $13.74 38.37% 1.6M |

Finance

PALI | $5.51 32.45% 28M |

Manufacturing

VERO | $0.804 31.8% 110K |

Health Technology

BACK | $4.37 30.45% 760K |

Health Care and Social Assistan...

---

Your saved searches

---